| Name: | Amikacin EP Impurity F |
| Catalogue No. | VL6230006 |
| CAS No. | 197909-67-4 |
| Molecular Formula | C26H50N6O15 |
| Molecular Weight | 686.72 g/ml |
| Status | In-Stock |
| IUPAC Name | 6-O-(3-amino-3-deoxy-α-D-glucopyranosyl)-4-O-[6-[(2S)-4-amino-2-hydroxybutanoyl]amino-6-deoxy-α-Dglucopyranosyl]-1-N-[(2S)-4-amino-2-hydroxybutanoyl]-2-deoxy-D-streptamine |
| Description | Amikacin EP Impurity F (CAS No: 197909-67-4) is an impurity formed during the synthesis of Amikacin or BB-K8, which is a semisynthetic, water-soluble, large-spectrum aminoglycoside antibiotic that is frequently administered parenterally for the treatment of Gram-negative infections. |
| References | Wang, Jian, et al. “Separation and Characterization of Unknown Impurities in Amikacin Sulfate by HPLC–MS N.” Chromatographia, vol. 78, no. 15-16, May 2015, pp. 1031–39,https://doi.org/10.1007/s10337-015-2909-8.Adams, E., et al. “Analysis of Amikacin by Liquid Chromatography with Pulsed Electrochemical Detection.” Journal of Chromatography A, vol. 819, no. 1-2, Sept. 1998, pp. 93–97,https://doi.org/10.1016/s0021-9673(98)00394-x. |
